Correlation analysis of Hashimoto’s thyroiditis with papillary thyroid carcinoma occurrence and its central lymph node metastasis: a single center experience

PurposeThis study investigates the clinicopathological characteristics of papillary thyroid carcinoma (PTC) with coexisting Hashimoto’s thyroiditis (HT) and further explores the risk factors for central lymph node metastasis (CLNM) in PTC.MethodA retrospective analysis was conducted on 415 PTC patie...

Full description

Saved in:
Bibliographic Details
Main Authors: Kang Sun, Xiaoming Wang, Dexuan Chen, Chaoqun Ma
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2024.1420998/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832086483510493184
author Kang Sun
Kang Sun
Xiaoming Wang
Dexuan Chen
Chaoqun Ma
author_facet Kang Sun
Kang Sun
Xiaoming Wang
Dexuan Chen
Chaoqun Ma
author_sort Kang Sun
collection DOAJ
description PurposeThis study investigates the clinicopathological characteristics of papillary thyroid carcinoma (PTC) with coexisting Hashimoto’s thyroiditis (HT) and further explores the risk factors for central lymph node metastasis (CLNM) in PTC.MethodA retrospective analysis was conducted on 415 PTC patients who underwent surgical treatment for thyroid cancer at the First Affiliated Hospital of Anhui University of Chinese Medicine from 2016 to 2022. Clinicopathological features were compared between PTC patients with and without HT. Univariate and multivariate logistic regression were used to analyze the risk factors of CLNM.ResultThe PTC+HT group had a higher proportion of female patients (85.5%) than the PTC group (P<0.05). Univariate analysis revealed no statistically significant difference between the two groups in eight aspects (all P>0.05). Multivariate analysis showed that HT was positively associated with the total number of central lymph node (CLN) dissected, Thyroid-stimulating hormone (TSH), Thyroid peroxidase antibody (TPOAb), and Thyroglobulin antibodies (TgAb), while identified as a protective factor against invasion with an odds ratio of 0.422 (95%CI 0.209-0.853, P=0.016). Through univariate and multivariate logistic regression, we proved that tumor position, Capsule + Extrathyroidal extension (ETE), multifocal tumors, and the total number of CLN dissected were independent risk factors for CLNM. Multiple linear regression analysis told us that invasion (β= 0.093, p=0.048) had a positively predictive impact on CLN positive rate.ConclusionFemale PTC patients are more prone to concurrent HT, which elevates the levels of TSH, TPOAb, and TgAb. HT not only promotes the longitudinal growth of nodules and PTC development, but also reduces the risk of invasion and CLNM. Therefore, we posit that the impact of HT on PTC patients is a “double-edged sword”. Isthmus, Capsule + ETE, multifocality, age < 55 years old, and male are high-risk factors for CLNM in PTC, while HT is regarded as a protective factor. Capsule + ETE is the primary risk factor affecting the CLN positive rate.
format Article
id doaj-art-1169e75a80a142f886ba1df217466ac2
institution Kabale University
issn 1664-2392
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj-art-1169e75a80a142f886ba1df217466ac22025-02-06T14:58:39ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-02-011510.3389/fendo.2024.14209981420998Correlation analysis of Hashimoto’s thyroiditis with papillary thyroid carcinoma occurrence and its central lymph node metastasis: a single center experienceKang Sun0Kang Sun1Xiaoming Wang2Dexuan Chen3Chaoqun Ma4Department of General Surgery, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of General Surgery, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, ChinaDepartment of General Surgery, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, ChinaDepartment of General Surgery, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of General Surgery, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaPurposeThis study investigates the clinicopathological characteristics of papillary thyroid carcinoma (PTC) with coexisting Hashimoto’s thyroiditis (HT) and further explores the risk factors for central lymph node metastasis (CLNM) in PTC.MethodA retrospective analysis was conducted on 415 PTC patients who underwent surgical treatment for thyroid cancer at the First Affiliated Hospital of Anhui University of Chinese Medicine from 2016 to 2022. Clinicopathological features were compared between PTC patients with and without HT. Univariate and multivariate logistic regression were used to analyze the risk factors of CLNM.ResultThe PTC+HT group had a higher proportion of female patients (85.5%) than the PTC group (P<0.05). Univariate analysis revealed no statistically significant difference between the two groups in eight aspects (all P>0.05). Multivariate analysis showed that HT was positively associated with the total number of central lymph node (CLN) dissected, Thyroid-stimulating hormone (TSH), Thyroid peroxidase antibody (TPOAb), and Thyroglobulin antibodies (TgAb), while identified as a protective factor against invasion with an odds ratio of 0.422 (95%CI 0.209-0.853, P=0.016). Through univariate and multivariate logistic regression, we proved that tumor position, Capsule + Extrathyroidal extension (ETE), multifocal tumors, and the total number of CLN dissected were independent risk factors for CLNM. Multiple linear regression analysis told us that invasion (β= 0.093, p=0.048) had a positively predictive impact on CLN positive rate.ConclusionFemale PTC patients are more prone to concurrent HT, which elevates the levels of TSH, TPOAb, and TgAb. HT not only promotes the longitudinal growth of nodules and PTC development, but also reduces the risk of invasion and CLNM. Therefore, we posit that the impact of HT on PTC patients is a “double-edged sword”. Isthmus, Capsule + ETE, multifocality, age < 55 years old, and male are high-risk factors for CLNM in PTC, while HT is regarded as a protective factor. Capsule + ETE is the primary risk factor affecting the CLN positive rate.https://www.frontiersin.org/articles/10.3389/fendo.2024.1420998/fullpapillary thyroid carcinomaHashimoto’s thyroiditiscentral lymph node metastasismultivariate analysisrisk factors
spellingShingle Kang Sun
Kang Sun
Xiaoming Wang
Dexuan Chen
Chaoqun Ma
Correlation analysis of Hashimoto’s thyroiditis with papillary thyroid carcinoma occurrence and its central lymph node metastasis: a single center experience
Frontiers in Endocrinology
papillary thyroid carcinoma
Hashimoto’s thyroiditis
central lymph node metastasis
multivariate analysis
risk factors
title Correlation analysis of Hashimoto’s thyroiditis with papillary thyroid carcinoma occurrence and its central lymph node metastasis: a single center experience
title_full Correlation analysis of Hashimoto’s thyroiditis with papillary thyroid carcinoma occurrence and its central lymph node metastasis: a single center experience
title_fullStr Correlation analysis of Hashimoto’s thyroiditis with papillary thyroid carcinoma occurrence and its central lymph node metastasis: a single center experience
title_full_unstemmed Correlation analysis of Hashimoto’s thyroiditis with papillary thyroid carcinoma occurrence and its central lymph node metastasis: a single center experience
title_short Correlation analysis of Hashimoto’s thyroiditis with papillary thyroid carcinoma occurrence and its central lymph node metastasis: a single center experience
title_sort correlation analysis of hashimoto s thyroiditis with papillary thyroid carcinoma occurrence and its central lymph node metastasis a single center experience
topic papillary thyroid carcinoma
Hashimoto’s thyroiditis
central lymph node metastasis
multivariate analysis
risk factors
url https://www.frontiersin.org/articles/10.3389/fendo.2024.1420998/full
work_keys_str_mv AT kangsun correlationanalysisofhashimotosthyroiditiswithpapillarythyroidcarcinomaoccurrenceanditscentrallymphnodemetastasisasinglecenterexperience
AT kangsun correlationanalysisofhashimotosthyroiditiswithpapillarythyroidcarcinomaoccurrenceanditscentrallymphnodemetastasisasinglecenterexperience
AT xiaomingwang correlationanalysisofhashimotosthyroiditiswithpapillarythyroidcarcinomaoccurrenceanditscentrallymphnodemetastasisasinglecenterexperience
AT dexuanchen correlationanalysisofhashimotosthyroiditiswithpapillarythyroidcarcinomaoccurrenceanditscentrallymphnodemetastasisasinglecenterexperience
AT chaoqunma correlationanalysisofhashimotosthyroiditiswithpapillarythyroidcarcinomaoccurrenceanditscentrallymphnodemetastasisasinglecenterexperience